NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE .2. DESIGN, SYNTHESIS, AND IN-VITRO ACTIVITY OF A SERIES OF 3-AMINO-6-ARYLOPYRIDIN-2-ONE TRIFLUOROMETHYL KETONES

被引:33
作者
DAMEWOOD, JR
EDWARDS, PD
FEENEY, S
GOMES, BC
STEELMAN, GB
TUTHILL, PA
WILIIAMS, JC
WARNER, P
WOOLSON, SA
WOLANIN, DJ
VEALE, CA
机构
[1] ZENECA INC,DEPT MED CHEM,ZENECA PHARMACEUT GRP,BUSINESS UNIT,WILMINGTON,DE 19897
[2] ZENECA INC,DEPT PHARMACOL,ZENECA PHARMACEUT GRP,BUSINESS UNIT,WILMINGTON,DE 19897
关键词
D O I
10.1021/jm00046a015
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of potent nonpeptidic inhibitors of the enzyme human leukocyte elastase (HLE) is reported. These inhibitors contain a 3-amino-2-pyridone ring as a central template in which the pyridone carbonyl and 3-position NH group are thought to form important hydrogen bonding interactions with the Val-216 residue of HLE. Substitution of the 6-position of the pyridone ring by various alkyl and aryl groups was found to afford increases in the in vitro potency of these inhibitors. A 6-position phenyl group, compound 10f, was found to result in a large increase in binding affinity, which was not obtained when the phenyl group was placed in either the 4- or 5-position of the molecule. Compound 10f was found to have good selectivity for HLE over other proteolytic enzymes, with the exception of bovine pancreatic chymotrypsin (BPC). Substitution of the 6-phenyl group in these molecules was found to decrease binding affinity for BPC without adversely affecting affinity for HLE.
引用
收藏
页码:3303 / 3312
页数:10
相关论文
共 42 条
  • [1] BERGESON S, 1990, Patent No. 4910190
  • [2] BERNSTEIN PB, J MED CHEM
  • [3] BERNSTEIN PR, 1992, Patent No. 509769
  • [4] X-RAY CRYSTAL-STRUCTURE OF THE COMPLEX OF HUMAN-LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE 3RD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR
    BODE, W
    WEI, AZ
    HUBER, R
    MEYER, E
    TRAVIS, J
    NEUMANN, S
    [J]. EMBO JOURNAL, 1986, 5 (10) : 2453 - 2458
  • [5] HUMAN-LEUKOCYTE AND PORCINE PANCREATIC ELASTASE - X-RAY CRYSTAL-STRUCTURES, MECHANISM, SUBSTRATE-SPECIFICITY, AND MECHANISM-BASED INHIBITORS
    BODE, W
    MEYER, E
    POWERS, JC
    [J]. BIOCHEMISTRY, 1989, 28 (05) : 1951 - 1963
  • [6] DETERMINING ATOM-CENTERED MONOPOLES FROM MOLECULAR ELECTROSTATIC POTENTIALS - THE NEED FOR HIGH SAMPLING DENSITY IN FORMAMIDE CONFORMATIONAL-ANALYSIS
    BRENEMAN, CM
    WIBERG, KB
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (03) : 361 - 373
  • [7] BROOKS CL, 1988, PROTEINS THEORETICAL
  • [8] DESIGN OF ORALLY-ACTIVE, NONPEPTIDIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE
    BROWN, FJ
    ANDISIK, DW
    BERNSTEIN, PR
    BRYANT, CB
    CECCARELLI, C
    DAMEWOOD, JR
    WOOLSON, SA
    EDWARDS, PD
    EARLEY, RA
    FEENEY, S
    GREEN, RC
    GOMES, B
    KOSMIDER, BJ
    KRELL, RD
    SHAW, A
    STEELMAN, GB
    THOMAS, RN
    VACEK, EP
    VEALE, CA
    TUTHILL, PA
    WARNER, P
    WILLIAMS, JC
    WOLANIN, DJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (09) : 1259 - 1261
  • [9] FREE-ENERGY CALCULATIONS ON BINDING AND CATALYSIS BY ALPHA-LYTIC PROTEASE - THE ROLE OF SUBSTRATE SIZE IN THE P1 POCKET
    CALDWELL, JW
    AGARD, DA
    KOLLMAN, PA
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1991, 10 (02): : 140 - 148
  • [10] CECCARELLI C, COMMUNICATION